EDIT vs MAR
Editas Medicine Inc (EDIT) versus Marriott International Inc (MAR) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Marriott International Inc (MAR) is a lodging company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported MAR revenue for 2025-12-31 was $26.19B. Net income was $2.60B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
EDIT currently screens at market cap $375.2M. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
Not investment advice. Open the EDIT and MAR stock pages for the full models.
Not investment advice.